Prestige Consumer Healthcare Inc. (PBH) News

Prestige Consumer Healthcare Inc. (PBH): $64.06

0.67 (-1.04%)

POWR Rating

Component Grades

Momentum

C

Stability

B

Sentiment

Quality

C

Add PBH to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#18 of 63

in industry

Filter PBH News Items

PBH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PBH News Highlights

  • PBH's 30 day story count now stands at 2.
  • Over the past 4 days, the trend for PBH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about PBH are DEC.

Latest PBH News From Around the Web

Below are the latest news stories about PRESTIGE CONSUMER HEALTHCARE INC that investors may wish to consider to help them evaluate PBH as an investment opportunity.

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Americaine® 20% Benzocaine Topical Anesthetic Spray Americaine® 20% Benzocaine Topical Anesthetic Spray TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray to the consumer level. While benzene is not an ingredient in any Americaine® 20% Benzocaine Topical Anesthetic Spray products, a recent review by our manufacturer and their th

Yahoo | December 22, 2023

Healthcare Sector Stocks: Consistent Above-Average Growth And Income

The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.

TalkMarkets.com | December 18, 2023

Should You Invest in Prestige Consumer Healthcare (PBH)?

Ariel Investments, an investment management company, released its “Ariel Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The third quarter saw losses in the U.S. stock market due to concerns about a government shutdown, autoworker strikes, rising oil prices, and the possibility that interest rates might stay higher for longer. […]

Yahoo | November 29, 2023

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from tw

Yahoo | November 24, 2023

Prestige Consumer Healthcare's (NYSE:PBH) investors will be pleased with their respectable 70% return over the last three years

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

Yahoo | November 8, 2023

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | November 8, 2023

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2024 Earnings Call Transcript

Prestige Consumer Healthcare Inc. (NYSE:PBH) Q2 2024 Earnings Call Transcript November 4, 2023 Operator: Good day, and thank you for standing by. Welcome to the Q2 2024 Prestige Consumer Healthcare Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your […]

Yahoo | November 5, 2023

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

Revenue of $286.3 Million in Q2, Ahead of OutlookDiluted EPS of $1.07 in Q2, Up Over 5% Versus Prior YearReduced Leverage Ratio to 3.0x at Quarter EndReaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2023. “Our second quarter results build on a strong first quarter performance than

Yahoo | November 2, 2023

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.

Yahoo | October 5, 2023

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Yahoo | September 29, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!